Left Lateral Positioning for Fetal Growth Restriction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether lying on the left side during pregnancy (left lateral recumbent positioning) can improve the growth of babies who aren't growing as expected. Researchers aim to determine if this position also affects the mother's overall health, stress levels, and the baby's heart function. Participants will either rest on their left side or receive regular care, with their physical activity tracked by a smartwatch. Pregnant individuals informed that their baby is smaller than expected and who are between 24 to 34 weeks pregnant might be suitable for this study. As an unphased study, this trial offers participants the opportunity to contribute to valuable research that could enhance pregnancy outcomes.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on anticoagulation therapy, you cannot participate in the trial.
What prior data suggests that left-lateral positioning is safe for pregnant individuals?
Research shows that lying on the left side is generally safe and comfortable for pregnant women. Studies have found that this position can improve blood flow to the placenta and increase oxygen delivery to the baby, potentially aiding the baby's growth.
No reports indicate negative effects from lying on the left side during pregnancy. In fact, this position might reduce risks associated with other positions, such as lying on the back, which can lower blood flow. Prospective participants in a study on this topic can feel confident that lying on the side is considered safe and might even benefit the baby's growth.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a simple and non-invasive method to potentially improve fetal growth in cases of fetal growth restriction. Unlike traditional medical interventions that might involve medication or more intensive monitoring, this approach simply involves pregnant individuals spending time in a left lateral recumbent position. This positioning may enhance blood flow to the placenta, potentially benefiting fetal development. Additionally, the trial's use of smartwatches to track participants' activity levels adds a modern twist, allowing for precise monitoring and personalized insights.
What evidence suggests that left-lateral positioning is effective for fetal growth restriction?
Research has shown that lying on the left side during pregnancy can improve blood flow to the uterus and placenta, aiding in oxygen delivery to the baby. One study found that blood flow decreased by 23% when mothers lay on their backs instead of their sides. Another study observed that resting on the left side increased fetal movements, often a sign of better health for the baby. Additionally, this position has been linked to more fetal urine production, indicating better fluid balance for the baby. In this trial, participants in the intervention group will practice left-lateral recumbent positioning to assess its potential benefits for fetal growth and health, especially in pregnancies where growth is a concern.12467
Who Is on the Research Team?
Manesha Putra, MD
Principal Investigator
University of Colorado Anschutz, Department of Obstetrics and Gynecology
Are You a Good Fit for This Trial?
This trial is for pregnant individuals between 24 and 34 weeks' gestation diagnosed with fetal growth restriction. They must be fluent in English or Spanish. The study excludes those not meeting these criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants practice left-lateral position daily for 4 hours with stretching, or receive standard care
Follow-up
Participants are monitored for maternal metabolomics, delivery outcomes, and fetal cardiac function
What Are the Treatments Tested in This Trial?
Interventions
- Left lateral recumbent positioning
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor